Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Five Year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis or Psoriatic Arthritis Who Are Treated With HUMIRA (Adalimumab)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01078558
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:14.466757+00:00
Published At
2019-07-05T00:00:00+00:00
Record Updated At
2019-07-05
Results Posted At
2019-07-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Rheumatoid Arthritis", "Psoriatic Arthritis", "Ankylosing Spondylitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-07-05"
protocolSection.identificationModule.nctId
"NCT01078558"
protocolSection.identificationModule.officialTitle
"A Five Year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis or Psoriatic Arthritis Who Are Treated With HUMIRA (Adalimumab)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-07-05"

Study condition terms

  • Rheumatoid Arthritis (protocolSection.conditionsModule.conditions)
  • Psoriatic Arthritis (protocolSection.conditionsModule.conditions)
  • Ankylosing Spondylitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.